• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SMN1基因纯合缺失的未受影响患者。

Unaffected patients with a homozygous absence of the SMN1 gene.

作者信息

Jedrzejowska Maria, Borkowska Janina, Zimowski Janusz, Kostera-Pruszczyk Anna, Milewski Michał, Jurek Marta, Sielska Danuta, Kostyk Ewa, Nyka Walenty, Zaremba Jacek, Hausmanowa-Petrusewicz Irena

机构信息

Neuromuscular Unit, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.

出版信息

Eur J Hum Genet. 2008 Aug;16(8):930-4. doi: 10.1038/ejhg.2008.41. Epub 2008 Mar 12.

DOI:10.1038/ejhg.2008.41
PMID:18337729
Abstract

In this report, we present three families in which we identified asymptomatic carriers of a homozygous absence of the SMN1 gene. In the first family, the bialleleic deletion was found in three of four siblings: two affected brothers (SMA type 3a and 3b) and a 25-years-old asymptomatic sister. All of them have four SMN2 copies. In the second family, four of six siblings are affected (three suffer from SMA2 and one from SMA3a), each with three SMN2 copies. The clinically asymptomatic 47-year-old father has the biallelic deletion and four SMN2 copies. In the third family, the biallelic SMN1 absence was found in a girl affected with SMA1 and in her healthy 53-years-old father who had five SMN2 copies. Our findings as well as those of other authors show that an increased number of SMN2 copies in healthy carriers of the biallelic SMN1 deletion is an important SMA phenotype modifier, but probably not the only one.

摘要

在本报告中,我们展示了三个家族,在这些家族中我们鉴定出了SMN1基因纯合缺失的无症状携带者。在第一个家族中,在四个兄弟姐妹中的三个身上发现了双等位基因缺失:两个患病兄弟(3a型和3b型脊髓性肌萎缩症)和一个25岁的无症状姐妹。他们都有4个SMN2拷贝。在第二个家族中,六个兄弟姐妹中有四个患病(三个患有2型脊髓性肌萎缩症,一个患有3a型脊髓性肌萎缩症),每人有3个SMN2拷贝。临床无症状的47岁父亲有双等位基因缺失和4个SMN2拷贝。在第三个家族中,在一名患有1型脊髓性肌萎缩症的女孩及其健康的53岁父亲身上发现了双等位基因SMN1缺失,其父亲有5个SMN2拷贝。我们的发现以及其他作者的发现表明,双等位基因SMN1缺失的健康携带者中SMN2拷贝数增加是一个重要的脊髓性肌萎缩症表型修饰因子,但可能不是唯一的修饰因子。

相似文献

1
Unaffected patients with a homozygous absence of the SMN1 gene.SMN1基因纯合缺失的未受影响患者。
Eur J Hum Genet. 2008 Aug;16(8):930-4. doi: 10.1038/ejhg.2008.41. Epub 2008 Mar 12.
2
Analysis of point mutations in the SMN1 gene in SMA patients bearing a single SMN1 copy.对携带单个SMN1基因拷贝的脊髓性肌萎缩症患者的SMN1基因点突变进行分析。
Neuromuscul Disord. 2007 Jun;17(6):476-81. doi: 10.1016/j.nmd.2007.03.003. Epub 2007 May 1.
3
Inverse correlation between SMN1 and SMN2 copy numbers: evidence for gene conversion from SMN2 to SMN1.SMN1与SMN2拷贝数之间的负相关:基因从SMN2转换为SMN1的证据。
Eur J Hum Genet. 2003 Mar;11(3):275-7. doi: 10.1038/sj.ejhg.5200957.
4
Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a highly efficient and reliable carrier-screening test.基于变性高效液相色谱法的生存运动神经元1和生存运动神经元2基因定量分析:一种高效可靠的携带者筛查检测方法
Hum Mutat. 2005 May;25(5):460-7. doi: 10.1002/humu.20160.
5
Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy.多重连接依赖探针扩增技术改善了脊髓性肌萎缩症的诊断。
Neuromuscul Disord. 2006 Dec;16(12):830-8. doi: 10.1016/j.nmd.2006.08.011. Epub 2006 Oct 17.
6
A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene.对西班牙脊髓性肌萎缩症患者进行的基因和表型分析,这些患者携带c.399_402del AGAG突变,这是SMN1基因中最常见的微小突变。
Hum Mutat. 2003 Aug;22(2):136-43. doi: 10.1002/humu.10245.
7
Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.新型2,4-二氨基喹唑啉衍生物作为SMN2启动子激活剂用于脊髓性肌萎缩症潜在治疗的合成与生物学评价
J Med Chem. 2008 Feb 14;51(3):449-69. doi: 10.1021/jm061475p. Epub 2008 Jan 19.
8
Investigation of the role of SMN1 and SMN2 haploinsufficiency as a risk factor for Hirayama's disease: clinical, neurophysiological and genetic characteristics in a Spanish series of 13 patients.探讨生存运动神经元1(SMN1)和生存运动神经元2(SMN2)单倍剂量不足作为平山病危险因素的作用:西班牙13例患者系列的临床、神经生理学和遗传学特征
Clin Neurol Neurosurg. 2007 Dec;109(10):844-8. doi: 10.1016/j.clineuro.2007.07.019. Epub 2007 Sep 11.
9
An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).常染色体隐性遗传性脊髓性肌萎缩症(SMA)中存活运动神经元基因(SMN1)突变谱的更新
Hum Mutat. 2000;15(3):228-37. doi: 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9.
10
Genetic testing and risk assessment for spinal muscular atrophy (SMA).脊髓性肌萎缩症(SMA)的基因检测与风险评估
Hum Genet. 2002 Dec;111(6):477-500. doi: 10.1007/s00439-002-0828-x. Epub 2002 Oct 3.

引用本文的文献

1
Application of Biomarkers in Spinal Muscular Atrophy.生物标志物在脊髓性肌萎缩症中的应用。
Int J Mol Sci. 2025 Jul 17;26(14):6887. doi: 10.3390/ijms26146887.
2
Spectrum of Phenotypes in SMA Patients With 4 Copies in the French Population: Registre SMA France.法国人群中具有4个拷贝的脊髓性肌萎缩症患者的表型谱:法国脊髓性肌萎缩症登记处
Neurol Genet. 2025 Apr 1;11(2):e200222. doi: 10.1212/NXG.0000000000200222. eCollection 2025 Apr.
3
5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2.
5qSMA:268例具有4个拷贝SMN2的患者的标准化回顾性自然史评估
J Neurol. 2024 May;271(5):2787-2797. doi: 10.1007/s00415-024-12188-5. Epub 2024 Feb 27.
4
Spinal Muscular Atrophy Treatment in Patients Identified by Newborn Screening-A Systematic Review.脊髓性肌萎缩症治疗在新生儿筛查识别患者中的应用:系统评价。
Genes (Basel). 2023 Jun 29;14(7):1377. doi: 10.3390/genes14071377.
5
The Birth Prevalence of Spinal Muscular Atrophy: A Population Specific Approach in Estonia.脊髓性肌萎缩症的出生患病率:爱沙尼亚的特定人群研究方法
Front Genet. 2021 Dec 22;12:796862. doi: 10.3389/fgene.2021.796862. eCollection 2021.
6
What Genetics Has Told Us and How It Can Inform Future Experiments for Spinal Muscular Atrophy, a Perspective.遗传学告诉了我们什么,以及它如何为未来的脊髓性肌萎缩症实验提供信息:一个视角。
Int J Mol Sci. 2021 Aug 6;22(16):8494. doi: 10.3390/ijms22168494.
7
Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy.观察 3 型脊髓性肌萎缩症的自然病程:来自波兰脊髓性肌萎缩症登记处的数据。
Orphanet J Rare Dis. 2021 Mar 24;16(1):150. doi: 10.1186/s13023-021-01771-y.
8
In Search of a Cure: The Development of Therapeutics to Alter the Progression of Spinal Muscular Atrophy.寻找治愈方法:改变脊髓性肌萎缩症进展的治疗方法的发展
Brain Sci. 2021 Feb 5;11(2):194. doi: 10.3390/brainsci11020194.
9
Spinal Muscular Atrophy: Mutations, Testing, and Clinical Relevance.脊髓性肌萎缩症:突变、检测及临床相关性
Appl Clin Genet. 2021 Jan 25;14:11-25. doi: 10.2147/TACG.S239603. eCollection 2021.
10
Advances in Newborn Screening and Presymptomatic Diagnosis of Spinal Muscular Atrophy.脊髓性肌萎缩症新生儿筛查及症状前诊断的进展
Degener Neurol Neuromuscul Dis. 2020 Dec 15;10:39-47. doi: 10.2147/DNND.S246907. eCollection 2020.